Sifted has named our co-founder and CEO, María Teresa Pérez Zaballos, among its 100 Women in Tech in Europe 2026, recognizing women shaping the future of European technology.
The recognition reflects María Teresa’s leadership at endogene.bio as we build a new approach to drug discovery for uterine health.
About endogene.bio
endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.
